下载掌阅APP，畅读海量书库
立即打开
［1］HEITZER E，HAQUE I S，ROBERTS C E S，et al.Current and future perspectives of liquid biopsies in genomics-driven oncology［J］.Nat Rev Genet，2019，20（2）：71-88.
［2］HAYES D F.Biomarker validation and testing［J］.Mol Oncol，2015，9（5）：96-966.
［3］ROSENTHAL D L，WOJCIK E M，KURTYCZ D F.The Paris System for Reporting Urinary Cytology［M］.Cham，Switzerland：Springer International Publishing，2016：1-159.
［4］中华预防医学会医院感染控制分会.临床微生物标本采集和送检指南［J］.中华医院感染学杂志，2018，28（20）：3192-3200.
［5］DUARTE J G，BLACKBURN J M.Advances in the development of human protein microarrays［J］.Expert Rev Proteomics，2017，14：627-641.
［6］KILICOGLU H.Biomedical text mining for research rigor and integrity：tasks，challenges，directions［J］.Brief Bioinform，2018，19（6）：1400-1414.
［7］KAMEL H F M，AL-AMODI H S.Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine［J］.Gen Proteom Bioinfor，2017，15：220-235.
［8］WANG D，WU L，LIU X.Glycan Markers as Potential Immunological Targets in Circulating Tumor Cells［J］.Adv Exp Med Biol，2017，994：275-284.
［9］HUANG Y，ZHU H.Protein Array-based Approaches for Biomarker Discovery in Cancer［J］.Gen Proteom Bioinfor，2017，15：73-81.
［10］TORÉN W，ANSARI D，ANDERSSON R.Immunohistochemical investigation of prognostic biomarkers inresected colorectal liver metastases：a systematic review and meta-analysis［J］.Cancer Cell Int，2018，18：217.
［11］MASUCCI G V，CESANO A，HAWTIN R，et al.Validation of biomarkers to predict response to immunotherapy in cancer：Volume Ⅰ-pre-analytical and analytical validation［J］.J Immunother Cancer，2016，4：76.
［12］DOBBIN K K，CESANO A，ALVAREZ J，et al.Validation of biomarkers to predict response to immunotherapy in cancer：Volume Ⅱ-clinical validation and regulatory considerations［J］.J Immunother Cancer，2016，4：77.
［13］SANDA M G，FENG Z，HOWARD D H，et al.Association Between Combined TMPRSS2：ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer［J］.JAMA Oncol，2017，3（8）：1085-1093.
［14］DUFFY M J，STURGEON C M，SOLETORMOS G，et al.Validation of new cancer biomarkers：a position statement from the European group on tumor markers［J］.Clin Chem，2015，61（6）：809-820.
［15］QU L，WANG Z L，CHEN Q，et al.Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma［J］.Eur Urol，2018，74（6）：756-763.
［16］RAGHAV K P，MAHAJAN S，YAO J C，et al.From Protocols to Publications：A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology［J］.J Clin Oncol，2015，33（31）：3583-3590.
［17］杨勇，雷孝锋，李尔华，等.《体外诊断试剂注册管理办法》解读［J］.分子诊断与治疗杂志，2015，7（4）：286-288.